Diagnosis of Peritoneal Dissemination: Comparison of 18F-FDG PET/CT, Diffusion-Weighted MRI, and Contrast-Enhanced MDCT
- 1 February 2011
- journal article
- research article
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 196 (2), 447-453
- https://doi.org/10.2214/ajr.10.4687
Abstract
OBJECTIVE. The purpose of this study was to compare the diagnostic performance of 18F-FDG PET/CT, MRI with and without diffusion-weighted imaging (DWI), and contrast-enhanced MDCT in the detection of peritoneal dissemination of malignant tumors. MATERIALS AND METHODS. We retrospectively evaluated the cases of 107 patients who underwent PET/CT and 130 patients who underwent MRI and contrast-enhanced MDCT. Twenty-six patients who underwent PET/CT and 23 who underwent MRI and contrast-enhanced MDCT were found to have peritoneal dissemination. All images were independently evaluated by two radiologists using a 5-point grading system. The results of PET/CT, T1- and T2-weighted MRI without DWI, MRI with DWI (b = 1,000 s/mm2), and contrast-enhanced MDCT were compared patient by patient and lesion by lesion by use of receiver operating characteristics analysis. Sensitivity, specificity, and positive predictive value were calculated and compared by use of the chi-square test. RESULTS. Patient by patient, the area under the receiver operating characteristics curve of MRI without DWI (0.88) was significantly less than that of the other modalities (contrast-enhanced MDCT, 0.91; MRI with DWI, 0.93; PET/CT, 0.97). The sensitivity of PET/CT (94%) was significantly higher than that of MRI without DWI (70%). The specificities of the modalities were not significantly different. In lesion-by-lesion analysis, MRI without DWI had significantly lower sensitivity (56%) than the other modalities (contrast-enhanced MDCT, 76%; MRI with DWI, 84%; PET/CT, 89%). The positive predictive value of PET/CT (93%) was significantly higher than that of the other three modalities (contrast-enhanced MDCT, 73%; MRI without DWI, 70%; MRI with DWI, 72%). CONCLUSION. PET/CT is the most useful technique for pathologic staging in the care of patients with malignant disease. If PET/CT is not available, DWI can be used as a screening tool.Keywords
This publication has 25 references indexed in Scilit:
- Diffusion-Weighted MRI in the Body: Applications and Challenges in OncologyAmerican Journal of Roentgenology, 2007
- Diffusion-weighted MR Imaging in Monitoring the Effect of a Vascular Targeting Agent on Rhabdomyosarcoma in RatsRadiology, 2005
- The accuracy of integrated PET-CT compared with dedicated pet alone for the staging of patients with nonsmall cell lung cancerThe Annals of Thoracic Surgery, 2004
- Head and Neck Cancer: Clinical Usefulness and Accuracy of PET/CT Image FusionRadiology, 2004
- Clinical Role of FDG PET in Evaluation of Cancer PatientsRadioGraphics, 2003
- Diffusion MRI for prediction of response of rectal cancer to chemoradiationThe Lancet, 2002
- POSITRON EMISSION TOMOGRAPHY IMAGING IN ONCOLOGYRadiologic Clinics of North America, 2001
- PET imaging in oncologySeminars in Nuclear Medicine, 2000
- Measurement of cell density and necrotic fraction in human melanoma xenografts by diffusion weighted magnetic resonance imagingMagnetic Resonance in Medicine, 2000
- Prospective comparison of 18 F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancerEuropean Journal of Nuclear Medicine and Molecular Imaging, 1998